ViroGates Investor Relations Material
Latest events
Q2 2024
ViroGates
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from ViroGates
Access all reports
ViroGates A/S is a medical technology company that develops and markets prognostic products for the healthcare sector. ViroGates offers Dynamis, a proprietary predictive model for estimating mortality in patients with severe sepsis in hospital, which can be used to trigger advanced solutions, improve patient monitoring, and evaluate interventions and clinical strategies.
Key slides for ViroGates
Q2 2024
ViroGates
Capital Raise
ViroGates
Latest articles
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
VIRO
Country
🇩🇰 Denmark